• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加洛帕米与普萘洛尔在清醒犬体内的药效学相互作用。

Pharmacodynamic interaction of gallopamil and propranolol in the conscious dog.

作者信息

Lehmann H D

出版信息

Arzneimittelforschung. 1985;35(12):1795-801.

PMID:4096731
Abstract

The interaction of gallopamil (Procorum) and propranolol was studied in conscious trained dogs by injecting gallopamil intravenously (consecutive injection of 0.0464, 0.1 and 0.215 mg/kg at 30-min intervals) with and without propranolol pre-medication (0.464 mg/kg i.v., 10 min before the first injection of gallopamil). An intraindividual comparison of the cardiovascular effects was made. The interaction was mostly minor and occurred only with the highest dose of gallopamil. It was noticeable most in the influence on myocardial contractility which was more pronounced than the influence on electrophysiological parameters. A shift in threshold doses was not observed. Much more pronounced effects of the gallopamil-propranolol interaction become apparent when the animals were at the same time subjected to vagal blockade (methylatropine). In this situation, combined administration of gallopamil and propranolol led to a greater reduction of contractility, increase of AV block and occurrence of asystole. As regards the latter, a shift in the threshold dose occurred. The differences in the intensity of the interaction between gallopamil and propranolol in animals with or without vagal blockade are therefore a consequence of the presence or absence of reflex regulation. The findings explain, and relativize, the clear-cut interaction in the anaesthetized dog demonstrated by other authors, i.e. experimental conditions matching an autonomic blockade.

摘要

通过静脉注射加洛帕米(普罗卡胺)(以30分钟的间隔连续注射0.0464、0.1和0.215mg/kg),在有或没有普萘洛尔预处理(静脉注射0.464mg/kg,在第一次注射加洛帕米前10分钟)的情况下,对清醒的训练犬进行了加洛帕米(普罗卡胺)与普萘洛尔相互作用的研究。进行了个体内心血管效应的比较。相互作用大多较小,仅在加洛帕米的最高剂量时出现。在对心肌收缩力的影响方面最为明显,比对电生理参数的影响更显著。未观察到阈剂量的变化。当动物同时接受迷走神经阻滞(甲基阿托品)时,加洛帕米-普萘洛尔相互作用的影响更为明显。在这种情况下,加洛帕米和普萘洛尔联合给药导致收缩力更大程度降低、房室传导阻滞增加和心脏停搏的发生。就后者而言,阈剂量发生了变化。因此,有或没有迷走神经阻滞的动物中加洛帕米和普萘洛尔之间相互作用强度的差异是反射调节存在或不存在的结果。这些发现解释并相对化了其他作者在麻醉犬中所证明的明显相互作用,即与自主神经阻滞相匹配的实验条件。

相似文献

1
Pharmacodynamic interaction of gallopamil and propranolol in the conscious dog.加洛帕米与普萘洛尔在清醒犬体内的药效学相互作用。
Arzneimittelforschung. 1985;35(12):1795-801.
2
Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.二氢吡啶类慢通道钙阻滞剂对清醒犬的比较作用:联合与不联合β肾上腺素能阻滞剂时的全身及冠状动脉血流动力学
J Pharmacol Exp Ther. 1984 Aug;230(2):367-75.
3
[Cardiodynamics of the conscious dog undergoing treadmill exercise, blood pressure reduction or isoproterenol and its modification by beta-blockade].
Dtsch Tierarztl Wochenschr. 1985 Apr 9;92(4):135-9.
4
Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.5-羟普萘洛尔(ORF 12592)对犬的心血管作用
Arch Int Pharmacodyn Ther. 1977 Jul;228(1):118-25.
5
Nifedipine-propranolol interaction: dependence of cardiovascular effects on plasma drug concentrations.
J Cardiovasc Pharmacol. 1987 Aug;10(2):182-9.
6
Differentiation of calcium ion antagonism and beta-adrenergic blockade.钙离子拮抗作用与β-肾上腺素能阻滞的鉴别
Clin Invest Med. 1980;3(1-2):9-12.
7
Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.地尔硫䓬、硝苯地平及维拉帕米的变时性、变力性和血管舒张作用。生理反应与膜受体活性的比较研究。
Circ Res. 1983 Feb;52(2 Pt 2):I29-39.
8
Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.卡托普利、普萘洛尔和维拉帕米对健康志愿者动脉脉搏波速度及其他心血管参数的影响。
Int J Clin Pharmacol Ther. 1998 Sep;36(9):483-9.
9
Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.维拉帕米所致心血管抑制:胰高血糖素的逆转作用及其与普萘洛尔的相互作用
Pharmacology. 1987;35(5):249-55. doi: 10.1159/000138317.
10
Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).一种新型强心剂MDL 17,043(1,3 - 二氢 - 4 - 甲基 - 5 - [4 - (甲硫基) - 苯甲酰基] - 2H - 咪唑 - 2 - 酮)的心血管特性
J Cardiovasc Pharmacol. 1982 May-Jun;4(3):500-8.